ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $25,735,000 | -7.9% | 1,055,164 | -2.6% | 0.03% | -17.6% |
| Q1 2021 | $27,937,000 | -68.9% | 1,082,824 | -35.5% | 0.03% | -70.9% |
| Q4 2020 | $89,799,000 | -2.6% | 1,679,739 | -24.9% | 0.12% | -18.8% |
| Q3 2020 | $92,229,000 | -7.3% | 2,235,863 | +9.0% | 0.14% | -15.8% |
| Q2 2020 | $99,452,000 | +65.0% | 2,051,821 | +43.8% | 0.17% | +32.6% |
| Q1 2020 | $60,264,000 | +16.6% | 1,426,382 | +18.1% | 0.13% | +41.8% |
| Q4 2019 | $51,664,000 | -26.0% | 1,207,675 | -37.8% | 0.09% | +24.7% |
| Q3 2019 | $69,838,000 | +628.8% | 1,940,500 | +441.3% | 0.07% | +247.6% |
| Q2 2019 | $9,583,000 | +25.8% | 358,500 | +26.3% | 0.02% | +23.5% |
| Q1 2019 | $7,620,000 | +140.7% | 283,800 | +44.9% | 0.02% | +112.5% |
| Q4 2018 | $3,166,000 | +10.1% | 195,800 | +41.4% | 0.01% | +33.3% |
| Q3 2018 | $2,875,000 | +27.7% | 138,500 | -6.1% | 0.01% | +20.0% |
| Q2 2018 | $2,252,000 | -85.7% | 147,500 | -79.0% | 0.01% | -87.2% |
| Q1 2018 | $15,770,000 | -63.1% | 701,833 | -50.6% | 0.04% | -64.5% |
| Q4 2017 | $42,782,000 | -14.7% | 1,420,860 | +6.7% | 0.11% | -22.5% |
| Q3 2017 | $50,179,000 | +106.3% | 1,332,055 | +40.8% | 0.14% | +89.3% |
| Q2 2017 | $24,318,000 | -9.8% | 945,838 | +20.6% | 0.08% | -14.8% |
| Q1 2017 | $26,962,000 | +12.3% | 784,238 | -5.8% | 0.09% | -1.1% |
| Q4 2016 | $24,018,000 | -18.8% | 832,814 | -10.5% | 0.09% | -19.8% |
| Q3 2016 | $29,584,000 | +0.0% | 930,011 | +11.4% | 0.11% | -3.5% |
| Q2 2016 | $29,574,000 | +450.5% | 834,727 | +168.2% | 0.12% | +379.2% |
| Q1 2016 | $5,372,000 | -37.0% | 311,216 | +30.2% | 0.02% | -33.3% |
| Q4 2015 | $8,521,000 | +74.5% | 239,027 | +61.9% | 0.04% | +71.4% |
| Q3 2015 | $4,883,000 | -60.3% | 147,645 | -41.3% | 0.02% | -58.0% |
| Q2 2015 | $12,287,000 | +246.2% | 251,736 | +142.4% | 0.05% | +233.3% |
| Q1 2015 | $3,549,000 | – | 103,864 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |